MILabs remotely installs from the Netherlands new E-Class PET/SPECT/CT at Osaka University of Pharmaceutical Sciences

Osaka, Japan and Utrecht, the Netherlands

May 4th, 2020

In a world with COVID-19 travel restrictions, MILabs has remotely completed the installation of a new E-Class VECTor6 system at the Osaka University of Pharmaceutical Sciences, Osaka, Japan. With the help of a local technician, this top-of-the-line multimodality PET/SPECT/CT system was put into operation by remote control from MILabs’ support facility in the Netherlands.

Osaka installations

According to Prof. Takashi Temma, Ph.D., Director of the Department of Biofunctional Analysis: “We are impressed by the robust design and remote support capabilities of this complex multimodal PET-SPECT-CT system. Besides delivering excellent imaging performance for each modality, the system also has the unique ability to run two assays labeled with different PET isotopes or PET/SPECT isotopes concurrently, in the same animal. Since we develop new diagnostic probes for biofunctional analysis, this MILabs system gives us the power advantage of within-subjects designs, resulting in more reliable results and the use of fewer disease models.”

Prof. Frederik Beekman, Ph.D., CEO/CSO comments: “We are excited that despite travel bans, we could get Prof. Temma’s system up and running for his routine use through remote control from our offices. The unique concurrent imaging capabilities of this multimodal system enables in a single imaging session to deliver more statistically reliable results than any other multimodal in-vivo imaging setup.”

About Osaka University of Pharmaceutical Sciences
The Osaka University of Pharmaceutical Sciences is dedicated to education and research in pharmaceutical sciences. Among its research objectives are the development of diagnostic and therapeutic methods using animal disease model by employing molecular imaging for early functional diagnosis, and evaluation of therapeutic effects on cancers. More specifically, the Biofunctional Analysis laboratory is focused on the design and development of radiolabeled probes for PET and SPECT imaging.

About MILabs B.V.

This fast-growing Dutch company has a history of providing a continuum of innovations to expand the applications preclinical molecular imaging. With its latest adaptive platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate PET, SPECT, Optical, and CT imaging either as stand-alone or fully integrated modalities on a single integrated system. For the commercialization of this preclinical imaging platform, MILabs was awarded the Commercial Innovation of the Year 2018 at the World Molecular Imaging Congress. For more information, visit: or contact MILabs at [email protected]

Share on social media

Beckman Institute welcomes new ultra-high-performance PET-CT scanner

Beckman Institute at the University of Illinois, Urbana-Champaign Improves Previous Imaging Functionality with Launch of ...
Read More →

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. ...
Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value ...
Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs ...
Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V ...
Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” ...
Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and ...
Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of ...
Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a ...
Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress ...
Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor ...
Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting ...
Read More →
Scroll to Top